Navigation Links
VirtualScopics Schedules Third Quarter 2012 Earnings Announcement
Date:10/25/2012

ROCHESTER, N.Y., Oct. 24, 2012 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ:   VSCP), a leading provider of quantitative imaging, today announced that before the market opens on Friday, November 9, 2012 it will release its third quarter 2012 financial results. VirtualScopics' President and Chief Executive Officer, Jeff Markin, and Chief Business and Financial Officer, Molly Henderson, will host a conference call that morning at 11:00 a.m. ET to provide a business update and discuss the company's results for the quarter ended September 30, 2012.

Interested participants should call 877-407-8035 when calling within the United States or
+1 201-689-8035 when calling internationally.  This call can also be accessed at www.virtualscopics.com and will be available for 30 days after the call.

About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development.  VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images.  In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster.  For more information about VirtualScopics, visit www.virtualscopics.com.

Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. These forward-looking statements include, but are not limite
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Aware, Inc. Reports Third Quarter 2012 Financial Results
2. University of Toronto wins third place at the Gates Foundations Reinvent the Toilet Challenge
3. Infection biology: The elusive third factor
4. Cracking the Neural Code: Third Annual Aspen Brain Forum
5. The Quarterly Review of Biology: Why some fats are worse than others
6. Evermedia Group Announces 375% Increase in Revenue for Second Quarter 2012
7. Medbox, Inc. Releases 2nd Quarter Financials
8. Westlake Chemical Increases Quarterly Dividend By Over 150%
9. Aware, Inc. Reports Second Quarter 2012 Financial Results
10. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
11. One-quarter of grouper species being fished to extinction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2015)... , March 24, 2015   Crossmatch ... solutions, today announced that its U.are.U ® ... retailer Goorin Bros . to achieve PCI ... solution secures access to the POS terminal, protecting ... risk of data breaches. With ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ) ... Sensors Market Forecast and Opportunities 2020" report ... is projected to grow at a CAGR over ... industrial and healthcare sectors are the key application ... adoption of MEMS technology in sensors is growing ...
(Date:3/18/2015)... , March 18, 2015 As ... businesses, new revolutionary smart wallets and apps continue to be ... currently entrenched in the mobile payment industry in focus today ... Holding Ltd. (NYSE: BABA ), Apple Inc. (NASDAQ: ... ) and Facebook Inc. (NASDAQ: FB ) ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
... become embedded in genomic DNA, which contains the complete ... for cells. It is known that ribonucleotides in DNA ... genomic instability and altered DNA metabolism, but not much ... A new study provides a mechanistic explanation of how ...
... MD -- The Biophysical Society has announced the ... to attend the Biophysical Society,s 56th Annual Meeting ... Diego, California, February 25-29, 2012. The purpose of ... interaction between American biophysicists and scientists working in ...
... can lead to climate change adaptation practices in ... "Climate-smart agriculture has the potential to increase sustainable ... climate impacts and mitigate climate change through greenhouse ... Neufeldt the lead expert on climate change at ...
Cached Biology News:Study identifies mechanisms cells use to remove bits of RNA from DNA strands 2Biophysical Society Announces winners of 2012 International Relations Committee travel awards 2Biophysical Society Announces winners of 2012 International Relations Committee travel awards 3Biophysical Society Announces winners of 2012 International Relations Committee travel awards 4Climate-smart agriculture should be livelihood-smart too 2Climate-smart agriculture should be livelihood-smart too 3
(Date:4/20/2015)... 2015   Meditope Biosciences, Inc ., a biotechnology ... today announced presentation of data demonstrating the use of ... conjugates (ADCs). The data were presented in an abstract at ... in Philadelphia . ... to the many commercial applications that may be possible ...
(Date:4/18/2015)... PHILADELPHIA , April 18, 2015 ... (NASDAQ: CRIS ) will be presenting data ... the American Associate of Cancer Research Annual Meeting ... ).      (Logo: http://photos.prnewswire.com/prnh/20130418/608115 ) ... its proprietary Nicotinamide phosphoribosyltransferase (NAMPT) small molecule inhibitors ...
(Date:4/17/2015)... 2015 CIO Review ( http://www.cioreview.com ) ... Most Promising Pharma and Life Science Technology Solution Providers ... compliance software platform for life sciences companies. , ... panel of experts and members of CIO Review’s editorial ... Platform has been on our radar for some time ...
(Date:4/17/2015)... 17, 2015  US-Australian drug discovery company, Novogen, today ... Understanding with the Feinstein Institute for Medical Research ... to collaborate with the objective of developing ... collaboration brings together the drug discovery expertise of ... the Feinstein Institute in neurosciences and oncology. ...
Breaking Biology Technology:Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Aurigene to Present its NAMPT and IRAK-4 Inhibitors Programs at AACR 2015 2MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6
... 3 Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: CPRX ... and commercializes prescription,drugs for the treatment of drug ... J. McEnany, Chief Executive,Officer, will be presenting an ... 10th Annual Global Investment Conference on Tuesday, November ...
... - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) announced ... its U.K. combination REOLYSIN(R) and docetaxel clinical trial,for ... of the Royal Surrey Hospital, U.K., presented the,results ... Cancer,(iSBTC) annual meeting on November 1, 2008. The ...
... AEterna Zentaris Inc.,(NASDAQ: AEZS ; TSX: AEZ), ... oncology, today reported that it has entered the,second ... trial in endometrial,cancer with AEZS-108, a luteinizing hormone-releasing ... enter the second stage of,patient recruitment was taken ...
Cached Biology Technology:Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference 2Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 3Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5
... are designed for sequencing inserts cloned into ... or T3 RNA polymerase promoters, or lambda ... at a concentration of 0.1 µg/µl in ... DNA sequencing reactions using SequiTherm™ EXCEL™ II ...
BD BioCoat Matrigel Matrix 35 mm Culture Dishes Coating : BD MatrigelTM Basement Membrane Matrix ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vo...
BD BioCoat Collagen I 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of rat tail collagen type I....
... with AutoGen AutoGenesys, BioRobotics BioPick, BioGrid, TAS ... picking systems This CLS number is a ... Cornings product number. If showing no availability ... number (D9314) or contact customer service for ...
Biology Products: